six, p 1.000; KO-FK506 vs WT-vehicle, p 0.380). We also observed related results with
6, p 1.000; KO-FK506 vs WT-vehicle, p 0.380). We also observed comparable outcomes with pCREB following therapy of PFC slices employing a distinctive CaN inhibitor, CsA (information not shown). With…